Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Vandivier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacy and Therapeutics|May 22, 2004
Use of exogenous erythropoietin in critically ill patientsR MacLaren, J Gasper, R Jung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activityL Yan, R W Vandivier, A F Suffredini, et al.
The European Respiratory Journal|January 9, 2009
Proactive integrated care improves quality of life in patients with COPDP B Koff, R H Jones, J M Cashman, et al.
Blood|October 1, 1996
Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxinH L Preas, D Reda, M Tropea, et al.
The Journal of Infectious Diseases|December 8, 1998
Detection of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta during experimental endotoxemia and human sepsisN P O'Grady, M Tropea, H L Preas, et al.
American Journal of Respiratory and Critical Care Medicine|August 25, 2001
Effect of endotoxin on ventilation and breath variability: role of cyclooxygenase pathwayH L Preas, A Jubran, R W Vandivier, et al.
Critical Care Medicine|July 1, 1996
Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trialP J Godin, L A Fleisher, A Eidsath, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Down-regulation of nitric oxide production by ibuprofen in human volunteersR W Vandivier, A Eidsath, S M Banks, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2018
Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancerE T Van Matre, P M Reynolds, R MacLaren, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacy and Therapeutics|May 22, 2004
Use of exogenous erythropoietin in critically ill patientsR MacLaren, J Gasper, R Jung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activityL Yan, R W Vandivier, A F Suffredini, et al.
The European Respiratory Journal|January 9, 2009
Proactive integrated care improves quality of life in patients with COPDP B Koff, R H Jones, J M Cashman, et al.
Blood|October 1, 1996
Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxinH L Preas, D Reda, M Tropea, et al.
The Journal of Infectious Diseases|December 8, 1998
Detection of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta during experimental endotoxemia and human sepsisN P O'Grady, M Tropea, H L Preas, et al.
American Journal of Respiratory and Critical Care Medicine|August 25, 2001
Effect of endotoxin on ventilation and breath variability: role of cyclooxygenase pathwayH L Preas, A Jubran, R W Vandivier, et al.
Critical Care Medicine|July 1, 1996
Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trialP J Godin, L A Fleisher, A Eidsath, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Down-regulation of nitric oxide production by ibuprofen in human volunteersR W Vandivier, A Eidsath, S M Banks, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2018
Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancerE T Van Matre, P M Reynolds, R MacLaren, et al.
Pageof 1